Sunnyvale, CA — January 26, 2010 — Today Labcyte introduced two pre-calibrated liquid class packages for use with its award-winning Echo® acoustic dispensers and POD™ 810 plate assemblers, which move liquids with sound. This expanded capability will allow its high throughput screening customers to not only transfer compounds in DMSO, but enables the transfer of a wide range of liquids necessary to assemble miniaturized assays for biochemical and cell-based screening. In addition the Echo platform can now address a wide range of growing applications in Genomics and Proteomics such as siRNA screening, real-time PCR genotyping, and protein-based arrays.
“Labcyte has revolutionized liquid handling with multiple systems in all of the top 10 pharmaceutical companies,” said Mark Fischer-Colbrie, Chief Executive Officer and President of Labcyte. “We are now positioned to offer the same guaranteed level of precision and accuracy to a brand new set of customers who are looking to miniaturize their assays while getting better results and cost savings due to the Echo platform’s ‘touchless’ dispensing capability.”
“The Echo Screening Package and the Echo Omics Package allow customers to change applications, on the fly, without the need for custom calibrations,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Support. “Our users can now run a wide range of applications where they need to transfer compounds in DMSO, or aqueous solutions that contain DNA, RNA or proteins, surfactants, and buffers. All of this is done without the use of disposable tips leading to better results and lower costs.”
Labcyte also introduced a 1536-well source plate which meets user requests for lower dead volume and increased working volume. The new 1536LDV plate cuts dead volume in half, increases the working volume by 12.5% and provides greater throughput compared to other 1536-well source plates.
About Labcyte
Labcyte Inc. uses sound to move liquids. This green technology provides significantly better analytical results while saving money. The ‘touchless’ technology provides dramatically better answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Labcyte technologies have broad applications including the fields of drug discovery including compound management, high-throughput and secondary screening; genomic research including PCR-based gene expression, DNA sequencing, RNAi studies and SNP analyses; proteomics including array formation and imaging mass spectrometry; mono-dispersed particle manufacturing, encapsulation, and live-cell transfer. Along with an outstanding presence in the pharmaceutical industry, Labcyte equipment is also found in leading CROs, academic and government institutions worldwide. Labcyte, headquartered in Sunnyvale, California, has 39 U.S., 7 European and two Japanese patents and additional U.S. and international filings. For more information, visit www.labcyte.com.
